US2023050166A1PendingUtilityA1

Method to treat vitiligo

Assignee: APIRX PHARMACEUTICAL USA LLCPriority: Aug 28, 2017Filed: Sep 29, 2022Published: Feb 16, 2023
Est. expiryAug 28, 2037(~11.1 yrs left)· nominal 20-yr term from priority
A61K 36/74A61K 31/658A61K 36/24A61P 17/00A61K 9/0014A61K 31/728A61K 36/9066A61K 31/201A61K 36/58A61K 31/352A61K 31/05
69
PatentIndex Score
0
Cited by
0
References
0
Claims

Abstract

A method to treat the skin condition vitiligo is described in this invention. The method comprises topical application of a composition containing cannabinoids, in particular cannabidiol and cannabigerol, at a concentration of 3%-20% by weight of the composition onto the affected skin area of a subject in need thereof. Application may be twice (2) daily for about six (6) weeks. Cannabidiol and cannabigerol may be sourced naturally or synthetically.

Claims

exact text as granted — not AI-modified
We claim: 
     
         1 . A method of treating vitiligo in a human in need thereof consisting essentially of topically administering to the human in need thereof a composition of more than 10 wt. % of cannabidiol and cannabigerol, wherein the human is administered low or trace amounts of Δ 9  tetrahydrocannabinol, and wherein the ratio of cannabigerol to cannabidiol is 2:1. 
     
     
         2 . The method of  claim 1 , wherein the cannabidiol and cannabigerol are from a natural source. 
     
     
         3 . The method of  claim 1 , wherein the cannabidiol and cannabigerol are synthetic. 
     
     
         4 . The method of  claim 1 , wherein the cannabidiol and cannabigerol are in powder form prior to use. 
     
     
         5 . The method of  claim 1 , wherein the cannabidiol and cannabigerol are in crystalline form prior to use. 
     
     
         6 . The method of  claim 1 , wherein the cannabidiol and cannabigerol are microencapsulated. 
     
     
         7 . The method of  claim 1 , wherein the cannabidiol and cannabigerol are nanoencapsulated with particle sizes of 20 to 40 nanometers. 
     
     
         8 . The method of  claim 1 , wherein the cannabidiol and cannabigerol further consists essentially of sodium oleyl hyaluronate. 
     
     
         9 . The method of  claim 1 , wherein the cannabidiol and cannabigerol further consist of at least one of omega-3 fatty acids or omega-6 fatty acids. 
     
     
         10 . The method of  claim 1 , wherein the cannabidiol and cannabigerol further consist essentially of neem extract,  Curcuma longa  extract,  Rubia cardifolia  extract, or  Wrightia tinctorial  extract. 
     
     
         11 . The method of  claim 1 , wherein the cannabidiol and cannabigerol further consist essentially of cacao butter. 
     
     
         12 . The method of  claim 1 , wherein the cannabidiol and cannabigerol are in a hydro gel form, a liquid form, a spray form, a powder form, or an ointment form. 
     
     
         13 . The method of  claim 1 , wherein the cannabidiol and cannabigerol are applied twice daily for six weeks onto affected skin areas of a human suffering from vitiligo.

Join the waitlist — get patent alerts

Track US2023050166A1 — get alerts on status changes and closely related new filings.

We store only your email — no account needed. See our privacy policy.